静息心率增快与心血管疾病(2)
[3] Cucherat M.Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post—myocardial infarction： a m eta—regression of randomized clinical trials[J]. Eur Heart J，2007，28(24)：3012—3019.
[4] Castagno D，Skali H，Takeuchi M ，et a1.Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure：results from the CHARM (Candesartan in Heart Failure：Assessment of Reduction in Mortality and morbidity)program[J]. J Am Coll Cardiol，2012，59(20)：1785—1795.
[5] Hildenbrand FF，Fauch6re I，Huber LC，et a1.A low resting heart rate at diagnosis predicts favourable long～term outcome in pulmonary arterial and chronic thromboembolie pulmonary hypertension.A prospective observational study[J]. Respir Res，2O12，13：76.
[6] Steg PG，Ferrari R，Ford I，et a1.Heart rate and use of beta--blockers in stable outpatients with coronary artery disease[J]. PLoS One，2012，7(5)：e36284.
[7] Fox K ，Ford I，Steg PG，et a1. Ivabradine for patients with stable coronary artery disease and left—ventricular systolic dysfunction (BEAUTIFUL)： a randomised， double—blind，placebo—controlled trial[J]. Lancet，2008，372(9641)：807—816. (刘庆 杨蓓)
[4] Castagno D，Skali H，Takeuchi M ，et a1.Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure：results from the CHARM (Candesartan in Heart Failure：Assessment of Reduction in Mortality and morbidity)program[J]. J Am Coll Cardiol，2012，59(20)：1785—1795.
[5] Hildenbrand FF，Fauch6re I，Huber LC，et a1.A low resting heart rate at diagnosis predicts favourable long～term outcome in pulmonary arterial and chronic thromboembolie pulmonary hypertension.A prospective observational study[J]. Respir Res，2O12，13：76.
[6] Steg PG，Ferrari R，Ford I，et a1.Heart rate and use of beta--blockers in stable outpatients with coronary artery disease[J]. PLoS One，2012，7(5)：e36284.
[7] Fox K ，Ford I，Steg PG，et a1. Ivabradine for patients with stable coronary artery disease and left—ventricular systolic dysfunction (BEAUTIFUL)： a randomised， double—blind，placebo—controlled trial[J]. Lancet，2008，372(9641)：807—816. (刘庆 杨蓓)